Gene Prediction Tools Market Size is set to Grow at a Remarkable Pace by 2033

In 2023, the Gene Prediction Tools Market size is expected to be worth US$ 127.3 million. The market is expected to reach US$ 680.9 million by 2033, expanding at an 18.3% CAGR throughout the forecast period.

The gene prediction tools industry is driven by the growing significance of genomics research and its applications in various fields. Growth is also attributed to advances in genomics research, increased use of personalized medicine, and rising demand for bioinformatics solutions.

Academic institutions, research centres, biotechnology & pharmaceutical businesses, and healthcare providers all use gene prediction systems. This segmentation aids in the identification of target consumer segments and customizing of marketing & sales strategies accordingly.

The use of artificial intelligence in genomics has grown in terms of prominence in recent years. Artificial intelligence is utilized to analyze genetic data and create personalized treatment regimens for patients.

The method considers an individual's genetic composition. It can also assist doctors in prescribing the most appropriate treatment for a specific patient. Such developments are further set to propel market expansion.

A need to understand the genetic basis of diseases and facilitate personalized therapy would help to push the market. Growing demand for speedy drug discovery, improvement in agricultural practices, and progression of genomics research in numerous domains would drive demand. These technologies are crucial in unlocking the potential of genomics data and transforming it into useful knowledge and applications.

Key Companies Profiled:

  • AZoLifeSciences
  • Softberry
  • DNASTAR
  • Qiagen
  • Illumina
  • CLC bio
  • BGI Genomics
  • Genscript
  • Exiqon
  • Geneious
  • Thermo Fisher Scientific

Browse More Details@ https://www.futuremarketinsights.com/reports/gene-prediction-tools-market

Gene Prediction Tools Market Outlook by Category

By Component:

  • Software
  • Service

By Application:

  • Diagnostics
  • Drug Discovery & Designing
  • Medical Research
  • Others

By End User:

  • Hospitals & Clinics
  • Academic Institutes & Research Centers
  • Biotechnology Companies
  • Life Science Technology Vendors
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more